Abstract

Pd-catalyzed C–H functionalization of mandelic acid and α-phenylglycine is reported. We have developed different protocols for the arylation, iodination, acetoxylation, and olefination of these substrates based on two different (Pd(II)/Pd(IV) and Pd(II)/Pd(0)) catalytic cycles. Four crucial features of these protocols are advantageous for practical applications. First, the α-hydroxyl and amino groups are protected with simple protecting groups such as acetates (Ac, Piv) and carbamates (Boc, Fmoc), respectively. Second, these protocols do not involve installation and removal of a directing group. Third, monoselectivity is accomplished. Fourth, no epimerization occurs at the vulnerable α-chiral centers.
1. Introduction
The selective, direct C–H functionalization of organic substrates by transition metal catalysts is a very attractive method for structural elaboration. Despite the impressive success in this area, one of the major challenges for these transformations remains the requirement to control site selectivity in molecules that contain multiple C–H bonds. Directed C–H functionalization has proven to be a reliable and powerful approach to utilize existing functional groups in a molecule to predictably guide C–H cleavage at a particular site.1 However, a number of limitations have prevented practical applications of these directed C–H reactions. First, existing functional groups are often modified to provide improved interactions with transition metal catalysts to promote catalytic C–H activation reactions. Second, reactions are often not compatible with coordinating functional groups. For example, the ubiquitous amino group needs to be specifically protected as phthalimide. The practical carbamate (Boc, Fmoc) protecting groups generally inhibit C–H activation reactions. Third, the formation of a mixture of mono- and di-o-C–H functionalization products is also a persistent problem facing the majority of directed C–H activation reactions.2 Therefore, development of catalysts, conditions, and directing groups to overcome these limitations is of central importance in the field. To achieve optimum efficiency in synthesis, the use of existing functional groups on a molecule of interest to direct C–H activation is most desirable. In this context, our group has been focused on the development of catalytic systems that utilize carboxylic acids and alcohols to direct C–H functionalization reactions.3 Not only are these functional groups commonly found in natural products and drug molecules, they are easily manipulated into a range of other functional groups making them highly versatile synthetic handles. In the long run, the development of a diverse range of directed C–H activation transformations based on existing functionality in a substrate will continue to grow and enhance the synthetic utility of these emerging methods.
We are especially interested in the diversification of naturally
occurring chiral compounds, aiming to expand the synthetic utility
of these readily available molecules as chiral synthons in asymmetric
synthesis. A number of naturally occurring chiral carboxylic acids
are readily available; however, there are only a few reports concerning
the use of free carboxylic acids to direct C–H functionalization
events in the literature,4 and the majority
of these established protocols are based on the derivatization of
simple benzoic acid derivatives which do not contain chiral centers.5 Other scaffolds such as phenylacetic acid, a
major class of synthetically versatile substrates, have been significantly
less investigated.3c,3d,6 Recently,
our group made strides on this front with the discovery that mono-N-protected
amino acid ligands could accelerate the Pd(II)/Pd(0) catalytic cycle
and demonstrated this reaction on phenylacetic acids, albeit limited
to olefination and cross-coupling via Pd(II)/Pd(0) redox catalysis.6c These ligand-accelerated reactions set the stage
for us to further investigate whether C–H activation methods
can be modified to directly functionalize enantiomerically pure α-substituted
phenylacetic acid substrates such as mandelic acid and α-phenylglycine.
We anticipate the key challenge is to achieve compatibility with α-functional groups protected with commonly used carbamates and acetates. If successful, rapid transformation of these readily available building blocks into diverse enantiomerically pure chiral synthons is feasible for asymmetric synthesis. Notably, these scaffolds can already be found in many pharmaceutical drugs (e.g., homatropine,7 cyclandelate,8 cefalexin,9 clopidogrel7), and the ability to directly derivatize them may lead to further medicinal investigation of these classes of compounds. Furthermore, we envisioned that by investigating the Pd(II)/Pd(IV) catalytic cycle in addition to previously reported Pd(II)/Pd(0) catalysis,10 new transformations would be achievable with this class of substrates ranging from C–C to C–X bond formations.
Herein, we describe a variety of o-C–H functionalizations of mandelic acid and α-phenylglycine derivatives based on two complementary catalytic cycles, namely Pd(II)/Pd(IV) and Pd(II)/Pd(0) catalysis. The α-amino groups in the substrates for C–H activation are protected with synthetically amenable carbamate (Boc, Fmoc). Notably, to the best of our knowledge, the Boc- and Fmoc-protected α-amino groups have not been shown to be compatible in carboxylate-directed C–H activations prior to this publication.3c Importantly, monoselectivity is achieved in all reactions through either optimizing conditions or choosing an appropriate ligand.
2. Results and Discussion
Pd(II)/Pd(IV) Arylation of Mandelic Acid
Our initial efforts toward the direct arylation of α-substituted phenylacetic acids focused on different Pd(II)/Pd(IV) protocols previously utilized in our lab11 and other groups.12 Because previously reported conditions are not compatible with phenylacetic acids,11,12 we proceeded to develop conditions for the direct arylation of pivaloyl-protected mandelic acid 1a employing aryl iodides. We initiated our optimization studies with 1 equiv of substrate 1a, 2 equiv of 4-iodotoluene 2a, 10 mol % of Pd(OAc)2, 2 equiv of AgOAc, 3 equiv of K3PO4, and DCE as solvent. The reaction mixture was stirred for 24 h at 100 °C. To our delight, we could detect the desired product 3a by 1H NMR analysis, although in a very low yield of 7% (Table 1, entry 1). On the basis of previous results from our group,11 we expected the solvent to play a crucial role for this transformation. Indeed, after changing the solvent to toluene, AcOH, or MeCN, no product was formed during the reaction, while other solvents such as DMF or tert-amylOH showed similar results to DCE (Table 1, entries 2–6). Interestingly, using HFIP (hexafluoroisopropanol) as solvent changed the outcome of the reaction dramatically, and the product was formed in 77% yield (Table 1, entry 7). Previous results have shown that HFIP can play a crucial role in palladium-catalyzed C–H functionalization reactions, particularly when utilizing weakly coordinating directing groups. Next, we investigated the influence of the additive by testing different silver and copper salts. Among the investigated additives, the initially used AgOAc showed the best activity, while Ag2CO3, Ag2O, and Cu(OAc)2 did not show good reactivity (Table 1, entries 8–10). The absence of AgOAc decreased the conversion significantly, supporting our hypothesis that this additive is crucial in regenerating the catalytically active palladium species from palladium iodides that may be formed after C–C reductive elimination from Pd(IV) after the oxidative addition of Pd(II) to an aryl iodide (Table 1, entry 11).10 The requirement for silver acetate is consistent with the Pd(II)/(IV) catalytic cycle.12 It is unlikely that the Pd(0)/Pd(II) catalytic cycle can operate under atmospheric air and in the presence of silver acetate, as these conditions are known to oxidize Pd(0) to Pd(II) and prevent oxidative addition of Pd(0) with ArI, which is the initiating step of the Pd(0)/Pd(II) catalytic cycle. Furthermore, acetates can facilitate the C–H bond activation step via promoting a CMD (concerted metalation deprotonation) mechanism,13 which may explain why KOAc performed the best among the tested bases (see SI). The reaction does not require any ligand, and the addition of pyridine and amino acid ligands decreased the yield slightly (see SI). Moreover, this reaction is not air and moisture sensitive and can be carried out under air with high yield, further contributing to this reaction’s operational simplicity. Finally, we could increase the yield to 90% by decreasing the reaction temperature to 80 °C (Table 1, entry 12). We were pleased to discover that no epimerization occurred and that the product could be obtained with 98% ee.
Table 1. Optimization of the Reaction Conditionsa,b.

| entry | solvent | additive | yield (%)b | entry | solvent | additive | yield (%)b |
|---|---|---|---|---|---|---|---|
| 1 | DCE | AgOAc | 7 | 7 | HFIP | AgOAc | 77 |
| 2 | MeCN | AgOAc | 0 | 8 | HFIP | Ag2CO3 | 30 |
| 3 | toluene | AgOAc | 0 | 9 | HFIP | Cu(OAc)2 | 8 |
| 4 | DMF | AgOAc | 10 | 10 | HFIP | Ag2O | 6 |
| 5 | AcOH | AgOAc | 0 | 11 | HFIP | - | 17 |
| 6 | tert-amylOH | AgOAc | 9 | 12 | HFIP | AgOAc | 90 (89)c,d,e |
Reaction conditions: 1a (0.1 mmol), 2a (0.2 mmol), Pd(OAc)2 (0.01 mmol), additive (0.2 mmol), K3PO4 (0.3 mmol), solvent (1 mL), air, 100 °C, 24 h.
Yield determined by 1H NMR analysis of crude reaction mixture using CH2Br2 as internal standard.
Reaction conditions: 1a (0.1 mmol), 2a (0.2 mmol), Pd(OAc)2 (0.005 mmol), AgOAc (0.2 mmol), KOAc (0.3 mmol), HFIP (1 mL), air, 80 °C, 24 h.
Yield of 3a after chromatographic purification.
98% ee, determined by chiral HPLC.
This reaction also works efficiently with simple protecting groups such as acetates (Table 2, entries 1 and 2), while tert-butyl or benzyl protecting groups gave lower conversion (Table 2, entries 3 and 4). Notably, we could exclusively obtain the monoarylated product 3mono and no diarylated 3di product was formed under these conditions. We assume that the α-substituent exerts an influence on the selectivity by inhibiting the second C–H bond insertion due to steric effects. In contrast to the observed monoselectivity, arylation of unsubstituted phenylacetic acid with 4-iodotoluene afforded mostly the diarylated product 5adi (Scheme 1).
Table 2. Investigation of Protecting Groups for Arylation of Mandelic Acida,b.

Reaction conditions: 1 (0.1 mmol), 2a (0.2 mmol), Pd(OAc)2 (0.005 mmol), AgOAc (0.2 mmol), KOAc (0.3 mmol), HFIP (1 mL), air, 80 °C, 24 h.
Determined by 1H NMR analysis of crude reaction mixture.
Yields of 3 after chromatographic purification.
Scheme 1. Arylation of Phenylacetic Acid 4a.

With this newly established arylation protocol, the scope of aryl iodide derivatives was examined. We found this catalytic method to be compatible with arene donors carrying a variety of different functional groups including alkyls (3a, 3e), electron-withdrawing groups such as trifluoromethyl (3f), esters (3g, 3h), ketones (3i), and aldehydes (3j) (Table 3). Phosphonates (3k) and acetates (3l) also worked well, while strong electron-donating groups such as methoxy (3m) or coordinating substituents such as nitro (3n) were less tolerated. Sterically demanding ortho-substituted aryls (e.g., 2-Me, 2-Cl) gave no conversion, but meta-substituted aryls (3e, 3h, 3l) showed good conversion and yields. Halides (3o, 3q, 3r) are also tolerated and can be used for further synthetic elaborations. Notably, no product was observed from C–H/C–Br coupling in the preparation of 3o and simple aryl bromides are not effective coupling partners for this reaction. Next, we probed the mandelic acid substrate scope. The best results were obtained with electron-withdrawing substituents such as chloride (3q and 3r) and trifluoromethyl (3s), while electron-rich substrates (e.g., 4-OMe) showed significant decarboxylation which was not observed with the simple phenylacetic acid substrate. It is worth noting here that protected α-phenylglycine derivatives (e.g., NHBoc, NHPiv, NPhth) were not appropriate for the present reaction, most likely since the nitrogen coordinates too strong to the palladium catalyst and thus inhibits the catalytic reactivity.
Table 3. Scope of Arylation Reactiona,b.

Reaction conditions: 1 (0.1 mmol), 2 (0.2 mmol), Pd(OAc)2 (0.005 mmol), AgOAc (0.2 mmol), KOAc (0.3 mmol), HFIP (1 mL), air, 80 °C, 24 h.
Yields after chromatographic purification.
The product was isolated as the corresponding methyl ester (see SI).
Acetoxylation and Iodination of Mandelic Acid
These findings prompted us to investigate other Pd(II)/Pd(IV)-catalyzed reactions. We were pleased to discover that addition of stoichiometric amounts of PhI(OAc)2 led to the ortho-acetoxylated product 6a.14 Further fine-tuning of the protocol was attempted in order to optimize this reaction. The reaction could be performed at 50 °C and delivered product 6a in 63% yield with 98% ee (Scheme 2). Additionally, we were interested in the iodination of substrate 1a,15 enabling easy access to halogenated mandelic acid derivatives which could be used for further C–C and C–N coupling reactions. We have previously developed several Pd-catalyzed C–H iodination protocols using inexpensive molecular iodine as reagent.16 Hence, we were interested if this approach could also be applicable in this case. Gratifyingly, we found that the addition of iodine to the reaction conditions formed product 7a in 51% yield and 98% ee.
Scheme 2. Iodination and Acetoxylation of Mandelic Acid 1a.

Pd(II)/Pd(0) Olefination Reaction of Mandelic Acid
While the Pd(II)/Pd(IV) catalysis worked well with the mandelic acid substrate 1a, poor reactivity was observed with Boc-protected α-phenylglycine under these conditions. In 2010,6c our group reported a ligand-accelerated Pd(II)-catalyzed C–H olefination17 protocol for phenylacetic acids. By using amino acid ligands in conjunction with O218 as a stoichiometric reoxidant, phenylacetic acid substrates could be coupled efficiently with terminal olefins in short reaction times. Our studies showed that monoprotected amino acids (MPAA) offer dramatic improvements in substrate scope, reaction rate, and catalyst lifetime. We anticipated this protocol to also be suitable for the olefination of pivaloyl-protected mandelic acid 1a. Indeed, the reaction of 1 equiv of 1a with 2 equiv of ethyl acrylate 8a, 5 mol % Pd(OAc)2, 15 mol % Ac-Gly-OH, 2 equiv of KHCO3, and tert-amylOH as solvent led to full conversion within 2 h. When carrying out this experiment without Ac-Gly-OH, only traces of the product 9a were formed, supporting our previously reported results. Consistent with our earlier observation,6d we obtained a mixture of mono- and di-ortho-olefinated product in a ratio of 2:1, respectively (Table 4, entry 1). It is of note that in this reaction, unlike the arylation, strong inherent bias for monoselectivity in the absence of ligands was not observed, which we attribute to a difference in sterics between aryl and olefinated products. Interestingly, changing the protecting group to tert-butyl led to even more diortho-olefinated product (Table 4, entry 3), while other protecting groups such as acetyl and benzyl showed reactivity similar to that of pivaloyl (Table 4, entries 2 and 4).
Table 4. Investigation of Protecting Groups for Olefination of Mandelic Acida,b.

| conv (%)b |
|||||
|---|---|---|---|---|---|
| entry | PG | no ligand | Ac-Gly-OH | mono:dib | yield (%)c |
| 1 | Piv | traces | 99 | 2:1 | 63 |
| 2 | Ac | traces | 91 | 2:1 | 45 |
| 3 | tBu | traces | 99 | 1:5 | n.i.d |
| 4 | Bn | traces | 99 | 2:1 | 62 |
Reaction conditions: 1 (0.1 mmol), 8a (0.2 mmol), Pd(OAc)2 (5 mol %), Ac-Gly-OH (15 mol %), KHCO3 (0.2 mmol), tert-amylOH (0.5 mL), O2 (1 atm), 90 °C, 2 h.
Determined by 1H NMR analysis of crude reaction mixture.
Yields of 9mono after chromatographic purification.
n.i. = not isolated.
Our efforts to achieve the monoselectivity of the olefination of mandelic acid 1a centered on the identification of an optimal ligand in terms of selectivity and reaction rate. On one hand, our previous ligandless conditions6c provided monoselectivity but did not afford sufficient reactivity with challenging substrates such as mandelic acid. On the other hand, MPAA ligands can accelerate both mono- and diolefination, and it is crucial to identify an appropriate ligand that can specifically accelerate the mono-olefination through a substrate–ligand match.6d Thus, we sought to identify the most efficient ligand backbones by examining a set of commercially available N-protected amino acids (Table 5). To increase operational simplicity, as well as safety, we decided to perform the reactions under 1 atm of air instead of 1 atm O2. The results indicate a direct correlation between the conversion and the ratio of 9amono:9adi. The higher the conversion, the more diolefinated product is formed. Among the tested amino acids, Ac-Tle-OH and Ac-Leu-OH showed the best reactivity (Table 5, entries 6 and 7). The mono-olefinated product 9amono could be isolated in 71% yield and 98% ee using Ac-Tle-OH. The ratio of 9amono:9adi could be pushed toward the diolefinated product by performing the reaction under 1 atm O2 (Table 5, entry 10). Subsequently, product 9adi was obtained in 82% yield by increasing the reaction temperature and extending the reaction time (Table 5, entry 11). This reaction showed, in general, good reactivity under air which makes it attractive for industrial large scale synthesis.
Table 5. Ligand-Controlled Mono- and Diselective Ortho-Olefinationa,b.

| entry | MPAA | 1a | 9amono | 9adi |
|---|---|---|---|---|
| 1 | - | 98 | traces | 0 |
| 2 | Ac-Gly-OH | 45 | 49 | traces |
| 3 | Ac-Val-OH | 42 | 50 | 5 |
| 4 | Ac-Phe-OH | 35 | 55 | 8 |
| 5 | Ac-lle-OH | 52 | 45 | traces |
| 6 | Ac-Tle-OH | 17 | 72 (71)c,d | 8 |
| 7 | Ac-Leu-OH | 16 | 66 | 14 |
| 8 | Boc-Leu-OH | 56 | 41 | traces |
| 9 | Bz-Leu-OH | 84 | 14 | 0 |
| 10e | Ac-Leu-OH | 0 | 65 | 33 |
| 11f | Ac-Leu-OH | 0 | 9 | 85 (82)g |
Reaction conditions: 1a (0.1 mmol), 8a (0.2 mmol), Pd(OAc)2 (5 mol %), MPAA (15 mol %), KHCO3 (0.2 mmol), t-AmylOH (0.5 mL), air, 80 °C, 3 h.
Conversion determined by 1H NMR analysis of crude reaction mixture.
Yield of 9amono after chromatographic purification.
98% ee, determined by chiral HPLC.
O2 (1 atm).
O2 (1 atm), 90 °C, 6h.
Yield of 9adi after chromatographic purification.
We next sought to examine the scope of the olefin coupling partner by subjecting various terminal olefins and 3-chloro-substituted mandelic acid 1e to the reaction conditions. It was decided to use Ac-Leu-OH as a ligand because this amino acid is less expensive than Ac-Tle-OH and no diolefinated product is formed due to the sterically bulky group in the meta-position of substrate 1e. In accordance with our earlier observations,6d this reaction works the best for the installation of the electron-withdrawing olefins such as acrylates (9f–h), styrenes (9i–k), and phosphonates (9l) (Table 6). Efforts to carry out the reaction with vinyl-sulfones, -sulfonates, and -nitriles were unsuccessful. Moreover, nonactivated terminal olefins such as n-hexene or n-butyl vinyl ether displayed low conversion. Different substituents on the mandelic acid substrate revealed that meta (9e) and para (9n and 9o) substituents resulted in good yield while ortho substituents (9m) showed lower conversion. In general, electron-withdrawing substituents worked better while an electron-donating group decreases the yield due to partial decarboxylation (9p). Ac-Gly-OH was used as ligand for the synthesis of racemic substrates 9n–p in order to avoid any match/mismatch effects between substrate and ligand.
Table 6. Scope of Olefination Reaction of Mandelic Acida,b.

Reaction conditions: 1 (0.1 mmol), 8 (0.2 mmol), Pd(OAc)2 (5 mol %), Ac-Leu-OH (15 mol %), KHCO3 (0.2 mmol), tert-amylOH (0.5 mL), O2 (1 atm), 80 °C, 3 h.
Yields after chromatographic purification.
Ac-Gly-OH instead of Ac-Leu-OH.
Pd(II)/Pd(0) Olefination of α-Phenylglycine
We were pleased to find that this catalytic system is not restricted to mandelic acid but also α-phenylglycine19 derivatives were suitable substrates (Table 7) which was not the case for the previous arylation protocol. NHBoc-protected α-phenylglycine showed the best result and reacted even in the absence of Ac-Gly-OH with good monoselectivity (Table 7, entry 1), which is not surprising considering the fact that NHBoc-protected α-phenylglycine can work as a MPAA type ligand and substrate simultaneously. Phthalimide and Fmoc have also been used as protecting groups albeit less effectively when compared to Boc (Table 7, entries 2 and 3). The NHAc-protected α-phenylglycine gave only low conversion (Table 7, entry 4). Presumably, the stronger coordination of the NHAc-group to palladium is prohibiting the C–H insertion step. Interestingly, all α-phenylglycine substrates formed the mono-ortho-olefinated product 11mono exclusively which we attribute to the steric hindrance of the NHPG.
Table 7. Investigation of Protecting Groups for α-Phenylglycinea,b.

| conv (%)b |
|||||
|---|---|---|---|---|---|
| entry | PG | no ligand | Ac-Gly-OH | mono:dib | yield (%)c |
| 1 | Boc | 68 | 85 | >20:1 | 80 |
| 2 | Phth | traces | 76 | >20:1 | 73 |
| 3 | Fmoc | traces | 72 | >20:1 | 67 |
| 4 | Ac | 0 | 10 | >20:1 | n.i.d |
Reaction conditions: 10 (0.1 mmol), 8a (0.2 mmol), Pd(OAc)2 (5 mol %), Ac-Gly-OH (15 mol %), KHCO3 (0.2 mmol), tert-amylOH (0.5 mL), O2 (1 atm), 90 °C, 2 h.
Determined by 1H NMR analysis of crude reaction mixture.
Yields of 11mono after chromatographic purification.
n.i. = not isolated.
A number of olefins reacted in a similar manner with the N-Boc-protected α-phenylglycine 10a (Table 8). The ortho-olefinated α-phenylglycine 11a could be isolated in 88% yield and 99% ee. To the best of our knowledge, this is the first protocol for the palladium-catalyzed direct functionalization of N-Boc-protected amino acids.
Table 8. Scope of Olefination Reaction of α-Phenylglycinea,b.

Reaction conditions: 10a (0.1 mmol), 8 (0.2 mmol), Pd(OAc)2 (5 mol %), Ac-Leu-OH (15 mol %), KHCO3 (0.2 mmol), tert-amylOH (0.5 mL), O2 (1 atm), 80 °C, 3 h.
Yields after chromatographic purification.
99% ee, determined by chiral HPLC.
We further demonstrated the scalability of both methods by conducting experiments on larger scale and prepared over 1 g of the products. As expected, the reaction works smoothly on gram-scale, and products 3a and 11a were isolated in 84% and 74% yield, respectively (Scheme 3). Importantly, the olefination of α-phenylglycine 1g was conducted under atmospheric air. In an attempt to lower the catalyst loading, we attempted the same reactions on 0.5 mmol scale, each with 2.5 mol % Pd(OAc)2. In the case of the olefination of Boc-protected α-phenylglycine, the 1H NMR yield was 59% and in the case of the arylation of pivaloyl-protected mandelic acid, the yield was 43% by 1H NMR.
Scheme 3. Gram-Scale Synthesis.

3. Conclusion
In conclusion, we have developed diverse and high yielding o-C–H functionalizations of readily available, enantiomerically pure pivaloyl-protected mandelic acid. Ortho-olefination of Boc-protected α-phenylglycine has also been achieved for the first time in this work. The installation of a directing group is not needed for these reactions, and monoselectivity is achieved by optimizing conditions or choosing a MPAA ligand. As a consequence, we expect these methodologies will be rapidly adopted to prepare diverse, chiral phenyl acetic acid derivatives for use in synthesis and medicinal chemistry.
4. Experimental Section
General Procedure for the Arylation of Mandelic Acid (Table 3)
An 8 mL vial with a fully covered solid Teflon-lined screw cap equipped with a magnetic stir bar was charged with the substrate (0.1 mmol, 1.0 equiv), ArI (0.2 mmol, 2.0 equiv), Pd(OAc)2 (1.1 mg, 0.005 mmol, 5 mol %), AgOAc (33 mg, 0.2 mmol, 2.0 equiv), KOAc (29 mg, 0.3 mmol, 3.0 equiv), and HFIP (1 mL). The vial was closed and stirred at 80 °C for 24 h. The reaction vessel was then cooled to rt. A 1.0 N HCl solution (1 mL) was then added, and the mixture was extracted with Et2O (3 × 3 mL). The organic layers were combined, filtered through a pad of Celite 545, and concentrated in vacuo. The resulting residue was purified by preparative TLC using 2:1 hexanes:EtOAc (with 1% HOAc) as the eluent.
General Procedure for the Acetoxylation of Mandelic Acid (Scheme 2)
An 8 mL vial with fully covered solid Teflon lined screw cap equipped with a magnetic stir bar was charged with the substrate (0.1 mmol, 1.0 equiv), PhI(OAc)2 (64 mg, 0.2 mmol, 2.0 equiv), Pd(OAc)2 (1.1 mg, 0.005 mmol, 5 mol %), KOAc (29 mg, 0.3 mmol, 3.0 equiv) and HFIP (1 mL). The vial was closed and stirred at 50 °C for 24 h. The reaction vessel was then cooled to rt. A 1.0 N HCl solution (1 mL) was then added, and the mixture was extracted with Et2O (3 × 3 mL). The organic layers were combined, filtered through a pad of Celite 545 and concentrated in vacuo. The resulting residue was purified by preparative TLC using 2:1 hexanes:EtOAc (with 1% HOAc) as the eluent.
General Procedure for the Iodination of Mandelic Acid (Scheme 2)
An 8 mL vial with fully covered solid Teflon-lined screw cap equipped with a magnetic stir bar was charged with the substrate (0.1 mmol, 1.0 equiv), I2 (51 mg, 0.2 mmol, 2.0 equiv), Pd(OAc)2 (1.1 mg, 0.005 mmol, 5 mol %), AgOAc (33 mg, 0.2 mmol, 2.0 equiv), KOAc (29 mg, 0.3 mmol, 3.0 equiv), and HFIP (1 mL). The vial was closed and stirred at 50 °C for 24 h. The reaction vessel was then cooled to rt. A 1.0 N HCl solution (1 mL) was then added, and the mixture was extracted with Et2O (3 × 3 mL). The organic layers were combined, filtered through a pad of Celite 545, and concentrated in vacuo. The resulting residue was purified by preparative TLC using 2:1 hexanes:EtOAc (with 1% HOAc) as the eluent.
General Procedure for the Olefination of Mandelic Acid and α-Phenylglycine (Tables 6 and 8)
An 8 mL vial with septum screw cap equipped with a magnetic stir bar was charged with the substrate (0.1 mmol, 1.0 equiv), Pd(OAc)2 (1.1 mg, 0.005 mmol, 5 mol %), Ac-Leu-OH (2.6 mg, 0.015 mmol, 15 mol %), and KHCO3 (20 mg, 0.2 mmol, 2.0 equiv). The vial was evacuated and flushed with O2 (three times, CAUTION! The reaction is run in a sealed vessel at elevated temperature under a 1 atm O2 environment. Though no incidents have been encountered in the submitters’ laboratory, it is nonetheless recommended that a blast shield be used while heating in larger scale). After adding dry tert-amylOH (0.5 mL) and the olefin coupling partner (0.2 mmol, 2.0 mmol) to the reaction mixture, the vial was closed with a fully covered solid Teflon lined cap and stirred at 80 °C for 3 h. The reaction vessel was then cooled to rt. A 1.0 N HCl solution (1 mL) was then added, and the mixture was extracted with Et2O (3 × 3 mL). The organic layers were combined, filtered through a pad of Celite 545, and concentrated in vacuo. The resulting residue was purified by preparative TLC using 2:1 hexanes:EtOAc (with 1% HOAc) as the eluent.
Acknowledgments
This work was supported by The Scripps Research Institute and the NIH (NIGMS, 2R01GM084019). N.D. gratefully acknowledges the Austrian Science Foundation (FWF, postdoctoral fellowship to N.D., J 3424-N28). T.T. acknowledges Asubio Pharma Co., Ltd. for the financial support.
Supporting Information Available
Detailed experimental procedures and characterization of new compounds. The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/jacs.5b04324.
The authors declare no competing financial interest.
Supplementary Material
References
- For selected reviews on σ-chelation-assisted C–H activation, see; a Kakiuchi F.; Sekine S.; Tanaka Y.; Kamatani A.; Sonoda M.; Chatani N.; Murai S. Bull. Chem. Soc. Jpn. 1995, 68, 62. 10.1246/bcsj.68.62. [DOI] [Google Scholar]; b Jun C.-H.; Hong J.-B.; Lee D.-Y. Synlett 1999, 1999, 1. 10.1055/s-1999-2520. [DOI] [Google Scholar]; c Daugulis O.; Do H.-Q.; Shabashov D. Acc. Chem. Res. 2009, 42, 1074. 10.1021/ar9000058. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Albrecht M. Chem. Rev. 2010, 110, 576. 10.1021/cr900279a. [DOI] [PubMed] [Google Scholar]; e Colby D. A.; Bergman R. G.; Ellman J. A. Chem. Rev. 2010, 110, 624. 10.1021/cr900005n. [DOI] [PMC free article] [PubMed] [Google Scholar]; f Yeung C. S.; Dong V. M. Chem. Rev. 2011, 111, 1215. 10.1021/cr100280d. [DOI] [PubMed] [Google Scholar]; g Engle K. M.; Mei T.-S.; Wasa M.; Yu J.-Q. Acc. Chem. Res. 2012, 45, 788. 10.1021/ar200185g. [DOI] [PMC free article] [PubMed] [Google Scholar]; h Neufeldt S. R.; Sanford M. S. Acc. Chem. Res. 2012, 45, 936. 10.1021/ar300014f. [DOI] [PMC free article] [PubMed] [Google Scholar]; i Ackermann L. Acc. Chem. Res. 2014, 47, 281. 10.1021/ar3002798. [DOI] [PubMed] [Google Scholar]
- For selected examples of mono- and diselectivity, see; a Murai S.; Kakiuchi F.; Sekine S.; Tanaka Y.; Kamatani A.; Sonoda M.; Chatani N. Nature 1993, 366, 529. 10.1038/366529a0. [DOI] [Google Scholar]; b Garcia-Rubia A.; Arrayas R. G.; Carretero J. C. Angew. Chem., Int. Ed. 2009, 48, 6511. 10.1002/anie.200902802. [DOI] [PubMed] [Google Scholar]; c Chernyak N.; Dudnik A. S.; Huang C.; Gevorgyan V. J. Am. Chem. Soc. 2010, 132, 8270. 10.1021/ja1033167. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Patureau F. W.; Glorius F. J. Am. Chem. Soc. 2010, 132, 9982. 10.1021/ja103834b. [DOI] [PubMed] [Google Scholar]; e Gulevich A. V.; Melkonyan F. S.; Sarkar D.; Gevorgyan V. J. Am. Chem. Soc. 2012, 134, 5528. 10.1021/ja3010545. [DOI] [PMC free article] [PubMed] [Google Scholar]; f Zhang X.-S.; Zhu Q.-L.; Zhang Y.-F.; Li Y.-B.; Shi Z.-J. Chem. - Eur. J. 2013, 19, 11898. 10.1002/chem.201300829. [DOI] [PubMed] [Google Scholar]; g Ackermann L. Org. Lett. 2005, 7, 3123. 10.1021/ol051216e. [DOI] [PubMed] [Google Scholar]; h Oi S.; Ogino Y.; Fukita S.; Inoue Y. Org. Lett. 2002, 4, 1783. 10.1021/ol025851l. [DOI] [PubMed] [Google Scholar]; i Hiroshima S.; Matsumura D.; Kochi T.; Kakiuchi F. Org. Lett. 2010, 12, 5318. 10.1021/ol102325f. [DOI] [PubMed] [Google Scholar]
- For selected examples, see; a Giri R.; Maugel N.; Li J.-J.; Wang D.-H.; Breazzano S. P.; Saunders L. B.; Yu J.-Q. J. Am. Chem. Soc. 2007, 129, 3510. 10.1021/ja0701614. [DOI] [PubMed] [Google Scholar]; b Giri R.; Yu J.-Q. J. Am. Chem. Soc. 2008, 130, 14082. 10.1021/ja8063827. [DOI] [PubMed] [Google Scholar]; c Wang D.-H.; Mei T.-S.; Yu J.-Q. J. Am. Chem. Soc. 2008, 130, 17676. 10.1021/ja806681z. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Zhang Y.-H.; Yu J.-Q. J. Am. Chem. Soc. 2009, 131, 14654. 10.1021/ja907198n. [DOI] [PubMed] [Google Scholar]; e Lu Y.; Wang D.-H.; Engle K. M.; Yu J.-Q. J. Am. Chem. Soc. 2010, 132, 5916. 10.1021/ja101909t. [DOI] [PMC free article] [PubMed] [Google Scholar]
- For reviews on carboxylate-directed C–H activation, see; a Satoh T.; Miura M. Synthesis 2010, 2010, 3395. 10.1055/s-0030-1258225. [DOI] [Google Scholar]; b Shi G.; Zhang Y. Adv. Synth. Catal. 2014, 356, 1419. 10.1002/adsc.201400028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- For selected examples, see; a Miura M.; Tsuda T.; Satoh T.; Pivsa-Art S.; Nomura M. J. Org. Chem. 1998, 63, 5211. 10.1021/jo980584b. [DOI] [Google Scholar]; b Chiong H. A.; Pham Q.-N.; Daugulis O. J. Am. Chem. Soc. 2007, 129, 9879. 10.1021/ja071845e. [DOI] [PubMed] [Google Scholar]; c Ueura K.; Satoh T.; Miura M. Org. Lett. 2007, 9, 1407. 10.1021/ol070406h. [DOI] [PubMed] [Google Scholar]; d Shimizu M.; Hirano K.; Satoh T.; Miura M. J. Org. Chem. 2009, 74, 3478. 10.1021/jo900396z. [DOI] [PubMed] [Google Scholar]; e Arroniz C.; Ironmonger A.; Rassias G.; Larrosa I. Org. Lett. 2013, 15, 910. 10.1021/ol400065j. [DOI] [PubMed] [Google Scholar]
- For selected examples of C–H functionalization of phenylacetic acid, see; a Shi B.-F.; Zhang Y.-H.; Lam J. K.; Wang D.-H.; Yu J.-Q. J. Am. Chem. Soc. 2010, 132, 460. 10.1021/ja909571z. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Mei T.-S.; Wang D.-H.; Yu J.-Q. Org. Lett. 2010, 12, 3140. 10.1021/ol1010483. [DOI] [PubMed] [Google Scholar]; c Wang D.-H.; Engle K. M.; Shi B.-F.; Yu J.-Q. Science 2010, 327, 315. 10.1126/science.1182512. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Engle K. M.; Wang D.-H.; Yu J.-Q. J. Am. Chem. Soc. 2010, 132, 14137. 10.1021/ja105044s. [DOI] [PMC free article] [PubMed] [Google Scholar]; e Engle K. M.; Thuy-Boun P. S.; Dang M.; Yu J.-Q. J. Am. Chem. Soc. 2011, 133, 18183. 10.1021/ja203978r. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manallack D. T.; Prankerd R. J.; Nassta G. C.; Ursu O.; Oprea T. I.; Chalmers D. K. ChemMedChem 2013, 8, 242. 10.1002/cmdc.201200507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhu C.; Lin X.; Wu J.; Wei Y. Anal. Sci. 2002, 18, 1055. 10.2116/analsci.18.1055. [DOI] [PubMed] [Google Scholar]
- Feng H.; Ding J.; Zhu D.; Liu X.; Xu X.; Zhang Y.; Zang S.; Wang D.-C.; Liu W. J. Am. Chem. Soc. 2014, 136, 14694. 10.1021/ja508388e. [DOI] [PubMed] [Google Scholar]
- For selected reviews, see; a Chen X.; Engle K. M.; Wang D.-H.; Yu J.-Q. Angew. Chem., Int. Ed. 2009, 48, 5094. 10.1002/anie.200806273. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Xu L.-M.; Li B.-J.; Yang Z.; Shi Z.-J. Chem. Soc. Rev. 2010, 39, 712. 10.1039/B809912J. [DOI] [PubMed] [Google Scholar]; c Sehnal P.; Taylor R. J. K.; Fairlamb I. J. S. Chem. Rev. 2010, 110, 824. 10.1021/cr9003242. [DOI] [PubMed] [Google Scholar]; d Lyons T. W.; Sanford M. S. Chem. Rev. 2010, 110, 1147. 10.1021/cr900184e. [DOI] [PMC free article] [PubMed] [Google Scholar]; e Topczewski J. J.; Sanford M. S. Chem. Sc. 2015, 6, 70. 10.1039/C4SC02591A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- For selected examples, see; a Wasa M.; Chan K. S. L.; Zhang X.-G.; He J.; Miura M.; Yu J.-Q. J. Am. Chem. Soc. 2012, 134, 18570. 10.1021/ja309325e. [DOI] [PMC free article] [PubMed] [Google Scholar]; b He J.; Li S.; Deng Y.; Fu H.; Laforteza B. N.; Spangler J. E.; Homs A.; Yu J.-Q. Science 2014, 343, 1216. 10.1126/science.1249198. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Gong W.; Zhang G.; Liu T.; Giri R.; Yu J.-Q. J. Am. Chem. Soc. 2014, 136, 16940. 10.1021/ja510233h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- For selected examples, see; a Zaitsev V. G.; Shabashov D.; Daugulis O. J. Am. Chem. Soc. 2005, 127, 13154. 10.1021/ja054549f. [DOI] [PubMed] [Google Scholar]; b Deprez N. R.; Sanford M. S. J. Am. Chem. Soc. 2009, 131, 11234. 10.1021/ja904116k. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Zhang S.-Y.; Li Q.; He G.; Nack W. A.; Chen G. J. Am. Chem. Soc. 2013, 135, 12135. 10.1021/ja406484v. [DOI] [PubMed] [Google Scholar]; d Zhang Q.; Chen K.; Rao W.; Zhang Y.; Chen F.-J.; Shi B.-F. Angew. Chem., Int. Ed. 2013, 52, 13588. 10.1002/anie.201306625. [DOI] [PubMed] [Google Scholar]
- For selected examples of the CMD-mechanism, see; a Gorelsky S. I.; Lapointe D.; Fagnou K. J. Am. Chem. Soc. 2008, 130, 10848. 10.1021/ja802533u. [DOI] [PubMed] [Google Scholar]; b Flegeau E. F.; Bruneau C.; Dixneuf P. H.; Jutand A. J. Am. Chem. Soc. 2011, 133, 10161. 10.1021/ja201462n. [DOI] [PubMed] [Google Scholar]; c Zhang S.; Shi L.; Ding Y. J. Am. Chem. Soc. 2011, 133, 20218. 10.1021/ja205294y. [DOI] [PubMed] [Google Scholar]; d Gorelsky S. I. Organometallics 2012, 31, 4631. 10.1021/om300230b. [DOI] [Google Scholar]
- For selected examples of Pd(II)-catalyzed acetoxylation, see; a Yoneyama T.; Crabtree R. H. J. Mol. Catal. A: Chem. 1996, 108, 35. 10.1016/1381-1169(95)00289-8. [DOI] [Google Scholar]; b Dick A. R.; Hull K. L.; Sanford M. S. J. Am. Chem. Soc. 2004, 126, 2300. 10.1021/ja031543m. [DOI] [PubMed] [Google Scholar]; c Desai L. V.; Hull K. L.; Sanford M. S. J. Am. Chem. Soc. 2004, 126, 9542. 10.1021/ja046831c. [DOI] [PubMed] [Google Scholar]; c1 Reddy B. V. S.; Reddy L. R.; Corey E. J. Org. Lett. 2006, 8, 3391. 10.1021/ol061389j. [DOI] [PubMed] [Google Scholar]; d Desai L. V.; Stowers K. J.; Sanford M. S. J. Am. Chem. Soc. 2008, 130, 13285. 10.1021/ja8045519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- For selected examples of Pd(II)-catalyzed iodination, see; a Giri R.; Chen X.; Yu J.-Q. Angew. Chem., Int. Ed. 2005, 44, 2112. 10.1002/anie.200462884. [DOI] [PubMed] [Google Scholar]; b Kalyani D.; Dick A. R.; Anani W. Q.; Sanford M. S. Org. Lett. 2006, 8, 2523. 10.1021/ol060747f. [DOI] [PubMed] [Google Scholar]; c Mei T.-S.; Giri R.; Maugel N.; Yu J.-Q. Angew. Chem., Int. Ed. 2008, 47, 5215. 10.1002/anie.200705613. [DOI] [PubMed] [Google Scholar]; d Aiso H.; Kochi T.; Mutsutani H.; Tanabe T.; Nishiyama S.; Kakiuchi F. J. Org. Chem. 2012, 77, 7718. 10.1021/jo3012286. [DOI] [PubMed] [Google Scholar]
- a Wang X.-C.; Hu Y.; Bonacorsi S.; Hong Y.; Burrell R.; Yu J.-Q. J. Am. Chem. Soc. 2013, 135, 10326. 10.1021/ja4055492. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Chu L.; Wang X.-C.; Moore C. E.; Rheingold A. L.; Yu J.-Q. J. Am. Chem. Soc. 2013, 135, 16344. 10.1021/ja408864c. [DOI] [PubMed] [Google Scholar]; c Chu L.; Xiao K.-J.; Yu J.-Q. Science 2014, 346, 451. 10.1126/science.1258538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- a Moritani I.; Fujiwara Y. Tetrahedron Lett. 1967, 8, 1119. 10.1016/S0040-4039(00)90648-8. [DOI] [Google Scholar]; b Fujiwara Y.; Noritani I.; Danno S.; Asano R.; Teranishi S. J. Am. Chem. Soc. 1969, 91, 7166. 10.1021/ja01053a047. [DOI] [PubMed] [Google Scholar]
- Campbell A. N.; Stahl S. S. Acc. Chem. Res. 2012, 45, 851. 10.1021/ar2002045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- For review on C–H bond functionalization of amino acids, see; Noisier A. F. M.; Brimble M. A. Chem. Rev. 2014, 114, 8775. 10.1021/cr500200x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
